Page last updated: 2024-08-24

plerixafor and Familial Nonmedullary Thyroid Cancer

plerixafor has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, SH; Cha, W; Jung, YH; Kim, BH; Kim, KH; Lee, DY; Sung, MW	1

Other Studies

1 other study(ies) available for plerixafor and Familial Nonmedullary Thyroid Cancer

Article	Year
Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells. Head & neck, 2016, Volume: 38, Issue:10 Topics: Animals; Benzylamines; Carcinogenesis; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunohistochemistry; Mice; Mice, Nude; Receptors, CXCR4; Thyroid Cancer, Papillary; Thyroid Neoplasms	2016

Article

Year

Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells.

Head & neck, 2016, Volume: 38, Issue:10

Topics: Animals; Benzylamines; Carcinogenesis; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunohistochemistry; Mice; Mice, Nude; Receptors, CXCR4; Thyroid Cancer, Papillary; Thyroid Neoplasms

2016